.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Harvard Business School
Daiichi Sankyo
Farmers Insurance
Cantor Fitzgerald
Merck
UBS
Deloitte
Accenture

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203183

« Back to Dashboard

NDA 203183 describes CISATRACURIUM BESYLATE, which is a drug marketed by Accord Hlthcare, Fresenius Kabi Usa, Jiangsu Hengrui Med, and Sandoz Inc, and is included in eight NDAs. It is available from three suppliers. Additional details are available on the CISATRACURIUM BESYLATE profile page.

The generic ingredient in CISATRACURIUM BESYLATE is cisatracurium besylate preservative free. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cisatracurium besylate preservative free profile page.

Summary for 203183

Tradename:1
Applicant:1
Ingredient:1
Patents:0

Pharmacology for NDA: 203183

Suppliers and Packaging for NDA: 203183

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 203183 ANDA Fresenius Kabi USA, LLC 63323-417 63323-417-10 10 VIAL in 1 CARTON (63323-417-10) > 10 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2MG BASE/ML
Approval Date:Feb 26, 2015TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Merck
Johnson and Johnson
Federal Trade Commission
Healthtrust
Julphar
Chinese Patent Office
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot